Relationship between Obesity-related Hormone Peptides and Quality of Life in Obese Women among Different Traditional Chinese Medicine Syndrome Groups

You-Lung Song；Chun-Ying Lien；Jung-Peng Chiu；Ching-Min Luo；Chia-Yu Liu；I-Ju Chen；Chung-Hua Hsu

Traditional Chinese medicine syndrome groups ； Obesity ； Quality of life ； Oesity-related hormone peptides

Journal of Traditional and Complementary Medicine

2卷1期（2012 / 01 / 01）

61 - 66

英文

The aim of this study was to explore the relationship between obesity-related hormone peptides and quality of life in obese women among different traditional Chinese medicine (TCM) syndrome groups (證型 zhèng xíng). 260 obese women met with age between 20 and 65 years old and body mass index (BMI) ≧ 27 kg/m^2, were recruited. The participants filled out a questionnaire on obese TCM syndrome groups, which was designed by professional TCM doctors, and two questionnaires on quality of life (QOL), WHOQOL-BREF Taiwan version and MOS Short Form-12 (SF-12). Data of biochemical characteristics and obesity-related hormone peptides were collected at the same time. According to the responses provided, the obese subjects were classified into spleen deficiency with dampness encumbrance syndrome (脾虛濕阻證 pí xū shī zǔ zhèng; SDD), stomach heat with dampness encumbrance syndrome (胃熱濕阻證 wèi rè shī zǔ zhèng; SHD), liver depression and qi stagnation syndrome (肝鬱氣滯證 gān yù qì zhì zhèng; LDQ), dual spleen-kidney deficiency syndrome (脾腎兩虛證 pí shèn liǎng xū zhèng; SKD), yin deficiency with internal heat syndrome (陰虛內熱證 yīn xū nèi rè zhèng; YDI) and a control group. For physical conditions, SDD group had significantly higher means in weight and BMI compared with the control group. The insulin and leptin levels in SHD group were significantly higher than those in the control group. The LDQ group showed marked decrease in mental condition scores compared with the control group. This study found that obese women in the SDD group were fatter than those in the control group. SHD group might have greater influence on the regulation of obesity-related hormone peptides. The LDQ group had poor QOL than the control group. Analysis of TCM syndrome groups among obese women merits further investigation.

1. Agin, A.,Jeandidier, N.,Gasser, F.,Grucker, D.,Sapin, R.(2006).Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: bi-insulin IRMA preliminary assessment.Clinical Chemistry and Laboratory Medicine,44,1379-1382.
2. Cummings, D.E.,Weigle, D.S.,Frayo, R.S.,Breen, P.A.,Ma, M.K.,Dellinger, E.P.,Purnell, J.Q.(2002).Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.The New England Journal of Medicine,346,1623-1630.
3. Dixon, J.B.(2010).The effect of obesity on health outcomes.Molecular and Cellular Endocrinology,316,104-108.
4. Fine, J.T.,Colditz, G.A.,Coakley, E.H.,Moseley, G.,Manson, J.E.,Willett, W.C.,Kawachi, I.(1999).A prospective study of weight change and health-related quality of life in women.JAMA,282,2136-2142.
5. Flier, J.S.,Maratos-Flier, E.(1998).Obesity and the hypothalamus: novel peptides for new pathways.Cell,92,437-440.
6. Fontaine, K.R.,Barofsky, I.(2001).Obesity and health-related quality of life.Obesity Reviews,2,173-182.
7. Gale, S.M.,Castracane, V.D.,Mantzoros, C.S.(2004).Energy homeostasis, obesity and eating disorders: recent advances in endocrinology.Journal of Nutrition,134,295-298.
8. Hsu, C.H.,Tsai, T.H.,Kao, Y.H.,Hwang, K.C.,Tseng, T.Y.,Chou. P.(2008).Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial.Clinical Nutrition,27,363-370.
9. Inui, A.,Asakawa, A.,Bowers, C.Y.,Mantovani, G.,Laviano, A.,Meguid, M.M.,Fujimiya, M.(2004).Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ.The Journal of the Federation of American Societies for Experimental Biology,18,439-456.
10. Jia, H.,Lubetkin, E.I.(2005).The impact of obesity on health-related quality-of-life in the general adult US population.Journal of Public Health,27,156-164.
11. Marchesini, G.,Bellini, M.,Natale, S.,Belsito, C.,Isacco, S.,Nuccitelli, C.,Pasqui, F.,Baraldi, L.,Forlani, G.,Melchionda, N.(2003).Psychiatric distress and health-related quality of life in obesity.Diabetes Nutrition and Metabolism,16,145-154.
12. Matthews, D.R.,Hosker, J.P.,Rudenski, A.S.,Naylor, B.A.,Treacher, D.F.,Turner, R.C.(1985).Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,28,412-419.
13. Mokdad, A.H.,Ford, E.S.,Bowman, B.A.,Dietz, W.H.,Vinicor, F.,Bales, V.S.,Marks, J.S.(2003).Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.JAMA,289,76-79.
14. Must, A.,Spadano, J.,Coakley, E.H.,Field, A.E.,Colditz, G.,Dietz, W.H.(1999).The disease burden associated with overweight and obesity.JAMA,282,1523-1529.
15. Peyrot, M.,Rubin, R.R.,Chen, X.,Frias, J.P.(2011).Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus.Diabetes Technology and Therapeutics,13,471-476.
16. Starr, J.I.,Mako, M.E.,Juhn, D.,Rubenstein, A.H.(1978).Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay.Journal of Laboratory and Clinical Medicine,91,683-392.
17. Ware, J., Jr.,Kosinksi, M.,Keller, S.D.(1996).A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity.Medical Care,34,220-233.
18. Ware, J.E.,Kosinski, M.,Keller, S.D.(1998).SF-12: How to score the SF-12 Physical and Mental Health Summary Scales.Lincoln, RI:QualityMetric Incorporated.
19. Wee, C.C.,Davis, R.B.,Hamel, M.B.(2008).Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity.Health and Quality Life Outcomes,6,11.
20. World Health Organization(2007).WHO International Standard terminologies on traditional medicine in the Western Pacific region.WHO.
21. Yao, G.,Chung, C.W.,Yu, C.F.,Wang, J.D.(2002).Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version.Journal of the Formosan Medical Association,101,342-351.
22. Zhu, Y.B.,Wang, Q.,Wu, C.Y.,Pang, G.M.,Zhao, J.X.,Shen, S.L.,Xia, Z.Y.,Yan, X.(2010).Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity.Chinese journal of Integrative Medicine,11,1023-1028.
23. Zigman, J.M.,Elmquist, J.K.(2003).Minireview: From anorexia to obesity - The yin and yang of body weight control.Endocrinology,144,3749-3756.

1. Li-Wen Huang,I-Ju Chen,Chung-Hua Hsu(2016).Influence of traditional Chinese medicine syndrome groups on quality of life in women with metabolic syndrome.Journal of Traditional and Complementary Medicine,6(4),404-408.
2. You-Lung Song,Lin-Huang Huang,I-Ju Chen,Chung-Hua Hsu,Ching-Min Luo,Chia-Yu Liu(2013).The Correlation of Lab Data, Hormone Peptides, Quality of Life, and Different Traditional Chinese Medicine Syndrome Groups in Type 2 Diabetes Patients.Journal of Traditional and Complementary Medicine,3(2),126-133.